Quest Diagnostics (DGX) to Acquire Haystack Oncology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Quest Diagnostics (NYSE: DGX), the nation s leading provider of diagnostic information services, and Haystack Oncology, an early-stage oncology.
Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.